Iowa prepares to award a second round of rural cancer-care hub contracts
Iowa health officials are approaching a scheduled decision on a second round of rural cancer-care hub contracts, a procurement that could expand chemotherapy, infusion and coordinated specialty services in communities outside the state’s largest medical centers.
Iowa HHS says it expects to post a Notice of Intent to Award on or around August 7, 2026. The date is informational and may change. As of August 5, the agency’s public notice repository did not list a notice for procurement COMPADM26008, the Round 2 Combat Cancer Health Hubs program.
The announcement will identify the apparent award decision. It will not, by itself, mean that contracts have been signed or that patient services have started.
Up to $26.7 million is available over five years
The IowaGrants opportunity is closed to new applications. The procurement offers an approximate total five-year award pool of $26,731,178, supported through the federal Rural Health Transformation Program.
That figure is an available pool, not a guaranteed payment to a particular provider or a promise that the entire amount will be awarded. Iowa HHS reserves the right to vary awards, reserve funds or award less based on factors including application quality, funding availability, statewide coverage and agency needs.
The anticipated project period runs from August 17, 2026, through September 30, 2031. The RFP scheduled applicant oral presentations, if requested by HHS, on or around August 3. The agency says the procurement schedule can be changed.
What the hub-and-spoke model would provide
Each proposed network must identify an Iowa-based hub and three rural spoke sites. Spokes may include community hospitals, critical-access hospitals, rural health clinics, federally qualified health centers and independent oncology practices. The procurement evaluates and financially supports three spoke sites per network unless HHS gives prior written approval for additional sites.
The goal is not for every rural facility to provide every cancer service. Instead, a hub would coordinate advanced care with nearby rural sites. The Round 2 RFP calls for new chemotherapy lines of service or expanded capacity at spoke locations, including additional infusion chairs, increased operating hours or other solutions that allow more patients to receive chemotherapy in rural communities.
Networks also would be expected to coordinate referrals, share records and data, conduct virtual visits and provide remote consultation from hub-based medical personnel. The plan specifically includes tele-oncology and virtual tumor boards, where clinicians at rural sites and hub facilities can collaborate on diagnoses and treatment plans.
When medically possible and appropriate, treatment could take place at the spoke site. Visits to the hub would be coordinated when advanced services are necessary, with the stated aim of reducing the amount of travel required to complete a care plan. The RFP describes that as an intended program effect, not a result already demonstrated by Round 2.
Round 2 follows five first-round awardees
In a June 18 announcement, Iowa HHS identified five first-round Combat Cancer Health Hub awardees: Ottumwa Regional Health Center, Wayne County Hospital, Shenandoah Medical Center, Greater Regional Medical Center and Mary Greeley Medical Center.
HHS said the first-round program is intended to establish hub-and-spoke cancer-care partnerships across Iowa, including telehealth, workforce recruitment and equipment investments. Round 2 may extend that network or address geographic coverage needs, but the final locations of the new hubs and spokes will be needed before residents can determine which communities will gain services or whether remaining gaps have been addressed.
HHS also launched Healthy Hometowns dashboards covering investments, awards by county and program outcomes. Those tools may provide additional information as Round 2 awards and contracts are finalized.
Award notice comes before contract and services
After applicants receive contract documents, successful applicants have 10 working days to negotiate and sign agreements. The RFP defines a contract as a later step in the process, so an intended award should not be treated as an executed agreement.
For patients and families, the next milestone is therefore the award notice—not an immediate change in local cancer treatment. Later announcements should identify the selected networks, hub and spoke locations, contract status and expected service launch dates.
Residents should also look for evidence about whether the program adds infusion capacity, expands specialty access and reduces repeated long-distance trips. The RFP describes those as intended effects; it does not establish that those results have already occurred.
Sources
Discover more from Interactive News
Subscribe to get the latest posts sent to your email.
